This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Los Angeles's Dr. Steven Giannotta Is Selected For "America's Top Doctors® For Cancer."

Dr. Steven Giannotta , a Board Certified Los Angeles , CA physician specializing in Neurological Surgery, has been selected for America's Top Doctors® for Cancer by Castle Connolly Medical Ltd.

LOS ANGELES, Nov. 27, 2012 /PRNewswire-USNewswire/ -- Castle Connolly Medical Ltd., America's trusted source for identifying Top Doctors, has published its 8th annual edition of America's Top Doctors® for Cancer and Los Angeles's Steven Giannotta , MD has been selected for inclusion.

(Photo: http://photos.prnewswire.com/prnh/20121127/DC19305)

The 8th edition of America's Top Doctors for Cancer includes over 2,600 top cancer care physicians in the United States. Selected physicians, including Dr. Giannotta, are among the top 1% of cancer doctors in over 40 specialties and subspecialties for the care and treatment of cancer.

Castle Connolly Top Doctors® for Cancer are selected each year by Castle Connolly Medical Ltd. after being nominated by peers in an online nomination process. Nominations are open to all board certified MDs and DOs and each year tens of thousands of physicians cast many tens of thousands of nominations. Nominated physicians are selected by the Castle Connolly physician-led research team based on criteria including medical education, training, hospital appointments, disciplinary histories and much more.

About Steven Giannotta: a short profile by and about the honoree:

Steven Giannotta MD leads one of the nations most prestigious neurosurgery departments. The Keck/ USC department has nationally recognized expertise in Vascular Disorders, Brain Tumors, Gamma Knife and Cyberknife Radiosurgery, Epilepsy, Parkinson's Disease, Complex Spine, Pediatric Neurosurgery, and Traumatic Brain Injury.

For more information on this Castle Connolly Top Doctor for Cancer, please visit Steven Giannotta 's profile on www.castleconnolly.com.

Castle Connolly Medical Ltd.'s President and CEO Dr. John Connolly has this to say about Dr. Giannotta's recognition: "The 8th edition of America's Top Doctors for Cancer , published in November 2012, is the most comprehensive guide of its kind and is the result of contributions from doctors and medical experts from across the United States. Dr. Giannotta was one of more than 2,600 cancer doctors nominated by Board Certified peers and selected by our research team at Castle Connolly Medical Ltd. Selection for the guide is an impressive accomplishment worthy of recognition. The United States is home to so many talented and committed cancer care professionals, yet some stand out. My congratulations to Dr. Giannotta."

To find out more or to contact Dr. Steven Giannotta of Los Angeles, CA, please call call 323-442-7540, or visit www.uscneurosurgery.com..

This press release was written by American Registry, LLC and Castle Connolly Medical Ltd., with approval by and/or contributions from Steven Giannotta and was distributed by PR Newswire, a subsidiary of UBM plc.

Castle Connolly Medical Ltd. identifies top doctors in America and provides consumers with detailed information about their education, training and special expertise in printed guides and online directories. It is important to note that doctors do not and cannot pay to be included in any Castle Connolly guide or online directory. Learn more at http://www.castleconnolly.com.

American Registry, LLC, recognizes excellence in top businesses and professionals. For more information, search The Registry™ at http://www.americanregistry.com.

Contact Info: Dr. Steven Giannotta Phone: 323-442-7540Email Address: giannott@usc.eduWebsite: www.uscneurosurgery.com

SOURCE American Registry

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,987.51 -61.49 -0.36%
S&P 500 1,985.54 -11.91 -0.60%
NASDAQ 4,567.5980 -24.2080 -0.53%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs